Skip to content

Painless Subconjunctival Antibiotic and Antifungal Injection in Corneal Ulcer Patients

Painless Subconjunctival Antibiotic and Antifungal Injection in Corneal Ulcer Patients.

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00789646
Enrollment
10
Registered
2008-11-13
Start date
2008-06-30
Completion date
2009-06-30
Last updated
2019-03-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Corneal Ulcer

Keywords

corneal ulcer, painless, subconjunctival injection, antibiotics, antifungal, lidocaine

Brief summary

The propose of this study is to determine the efficacy of 2% xylocaine in reducing pain due to subconjunctival antibiotic and antifungal injection.

Interventions

PROCEDURELidocaine/NSS

First injection: subconjunctival 2% lidocaine without adrenaline 0.4 ml. before antibiotic injection Second injection (24 hours later): subconjunctival NSS 0.4 ml. before antibiotic injection

PROCEDURENSS/Lidocaine

First injection: subconjunctival NSS 0.4 ml. before antibiotic injection Second injection (24 hours later): subconjunctival 2% lidocaine without adrenaline 0.4 ml. before antibiotic injection

Sponsors

Mahidol University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* The corneal ulcer patients who are diagnosed by ophthalmologist and have 2 of 3 in these following features. 1. corneal epithelial defect with stromal infiltration 2. reaction in anterior chamber 3. positive for bacteria or fungus * The patients have to receive subconjunctival antibiotic injection twice at least. * The patients must be informed consent.

Exclusion criteria

* The patients who have history of allergy of local anesthetics, antibiotics or antifungal drugs. * The patients who administered NSAIDs or weak opioids within 24 hours prior to subconjunctival antibiotic/antifungal injection. * Unable to cooperate with the treatment. * Pregnant women

Design outcomes

Primary

MeasureTime frame
Numeric rating scaleimmediately after injection

Secondary

MeasureTime frame
Side effects24 hours after injection

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026